Newsletters and Deep Dive digital magazine
First use for Imbruvica outside blood cancer.
The drug is also granted Orphan Drug Designation by the FDA.
Company will cut its headcount by 35%, as it waits for an FDA decision on its diabetes DTx.
An inside guide to unlocking clinical research in the UK